Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 11:03 AM ET

Healthcare Equipment and Supplies

Company Overview of CardioMEMS, Inc.

Company Overview

CardioMEMS, Inc. develops and commercializes a wireless sensing and communication technology for the human body. The company's technology platform improves the management of severe chronic cardiovascular diseases, such as heart failure, hypertension, and aneurysms. The company’s miniature wireless sensors are implanted using minimally invasive techniques, which transmit cardiac output, blood pressure, and heart rate data. It offers CardioMEMS HF System, a heart failure monitoring device; and EndoSure Wireless AAA Pressure Measurement System that is inserted during the minimally invasive endovascular repair of abdominal aortic aneurysms or AAA through a catheter into a patient's aneurysm sac,...

387 Technology Circle NW

Suite 500

Atlanta, GA 30313

United States

Founded in 2000

106 Employees





Key Executives for CardioMEMS, Inc.

Co-Founder and Director
Age: 52
Chief Operating Officer
Age: 45
Chief Information Officer
Compensation as of Fiscal Year 2015.

CardioMEMS, Inc. Key Developments

St. Jude Medical, Inc. and CardioMEMS Announces U.S. Food and Drug Administration Approval of the CardioMEMS HF System

St. Jude Medical, Inc. and CardioMEMS announced U.S. Food and Drug Administration (FDA) approval of the CardioMEMS HF System. The CardioMEMS HF System is the first and only FDA-approved heart failure monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure. The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery. The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery (PA) during a minimally invasive procedure to directly measure PA pressure. Directly measuring PA pressure via a procedure called a right-heart catheterization is a standard-of-care practice for managing worsening HF in patients who have been hospitalized. The CardioMEMS HF System allows patients to transmit the same information from their homes to their health care providers allowing for personalized and proactive management to reduce the likelihood of hospitalization. Heart failure occurs when the heart is unable to pump enough blood to meet the body's demands and blood pressure within the heart is elevated. Significant HF progression over a period of days is known as acute decompensation and leads to hospitalization. Increased PA pressures often precede indirect measures of worsening HF such as weight and blood pressure changes. The CardioMEMS HF System allows clinicians to stabilize PA pressures by proactively managing medications and other treatment options while also providing an early indication of worsening HF.

Similar Private Companies By Industry

Company Name Region
EndoEvolution, LLC United States
In-X Corporation United States
AeroMed, Inc. United States
Luzerne Optical Laboratories, Ltd. United States
Rio Grande Neurosciences Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CardioMEMS, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at